|
Synonyms
|
IL-1RN, IRAP
|
|
Species
|
Murine
|
|
Accession
|
Q542W1
|
|
GeneID
|
16181
|
|
Source
|
重组鼠白介素-1受体拮抗剂蛋白蛋白Escherichia coli.
|
|
Molecular Weight
|
Approximately 17.3 kDa, a single non-glycosylated polypeptide chain containing 152 amino acids.
|
|
Quantity
|
20µg/100µg/1000µg
|
|
AA Sequence
|
重组鼠白介素-1受体拮抗剂蛋白蛋白RPSGKRPCKM QAFRIWDTNQ KTFYLRNNQL IAGYLQGPNI KLEEKIDMVP IDLHSVFLGI HGGKLCLSCA KSGDDIKLQL EEVNITDLSK NKEEDKRFTF IRSEKGPTTS FESAACPGWF LCTTLEADRP VSLTNTPEEP LIVTKFYFQE DQ
|
|
Purity
|
> 97 % by SDS-PAGE and HPLC analyses.
|
|
Biological Activity
|
Fully biologically active when compared to standard. The ED50 as determined by inhibiting IL-1α-dependent proliferation of murine D10S cells is less than 50 ng/ml, corresponding to a specific activity of > 2.0 × 104 IU/mg in the presence of 50 pg/ml rHuIL-1α.
|
|
Physical Appearance
|
重组鼠白介素-1受体拮抗剂蛋白蛋白Sterile Filtered White lyophilized (freeze-dried) powder.
|
|
Formulation
|
Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4.
|
|
Endotoxin
|
Less than 1 EU/µg of rMuIL-1RA as determined by LAL method.
|
|
Reconstitution
|
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
|
|
Storage
|
This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
|
|
重组鼠白介素-1受体拮抗剂蛋白蛋白
|
|
|
SDS-PAGE
|
|
|
Reference
|
1. Dinarello CA. 1994. FASEB J. 8:1314-25.
2. Patterson D, Jones C, Hart I, et al. 1993. Genomics. 15:173-6.
3. Steinkasserer A, Spurr NK, Cox S, et al. 1992. Genomics. 13:654-7.
4. Perrier S, Darakhshan F, Hajduch E. 2006. FEBS Lett. 580:6289-94.
5. Gabay C, Porter B, Fantuzzi G, et al. 1997. J Immunol. 159:5905-13.
|
|
Background
|
IL-1RA was initially called the IL-1 inhibitor which is encoded by the IL1RN gene and it is a member of the interleukin 1 cytokine family. IL-1RA is secreted by various types of cells including immune cells, epithelial cells, and adipocytes. IL-RA has functions of inhibiting the activity of interleukin-1 by binding to receptor IL1R1 and preventing its association with the coreceptor IL1RAP for signaling. IL-1RA is also used in the treatment of rheumatoid arthritis, an autoimmune disease in which IL-1 plays a key role. The murine IL-1RA is a single non-glycosylated polypeptide chain containing 152 amino acids and it has been shown to block the inflammatory responses induced by IL-1 both in vitro and in vivo. The protein shows 26 % amino acid homology to IL-1β and 19% homology to IL-1α. It also shares 90 % a.a. sequence identity with rat IL-1RA.
|
